Stories

Study: Lifesaving antibiotics increase risk of lifelong hearing loss in patients with deadly bacterial infections

July 29, 2015

Seeking to stem the tide of permanent hearing loss from the use of lifesaving antibiotics, researchers at Oregon Health & Science University have found that patients stricken with dangerous bacterial infections are at greater risk of hearing loss than previously recognized.

Breast cancer survivors who experience pain during intercourse may benefit from lidocaine treatment

July 27, 2015

Scientists at Oregon Health & Science University report that breast cancer survivors who experience pain during sexual intercourse, a common side effect of breast cancer treatment, may achieve comfort when liquid lidocaine is applied strategically to prevent pain.

OHSU and Doernbecher Children’s Hospital foundation boards announce new members

July 21, 2015

New members appointed to the Doernbecher Children’s Hospital Foundation Board of Directors and the OHSU Foundation Board of Trustees.

Grant applicants sought for OHSU program to reduce cancer’s impact on Oregonians

July 20, 2015

The Knight Cancer Institute at Oregon Health & Science University (OHSU) is seeking grant applicants statewide to receive funding through a program dedicated to supporting community-specific projects that meet cancer-related needs.

Magnetic pulses to the brain deliver long-lasting relief for tinnitus patients: VA and OHSU study

July 16, 2015

In the largest U.S. clinical trial of its kind funded by the Veterans Affairs (VA) Rehabilitation Research and Development Service, researchers at the VA Portland Medical Center and Oregon Health & Science University found that transcranial magnetic stimulation significantly improved tinnitus symptoms for more than half of study participants.

OHSU scientists unlock first critical step toward gene therapy treatment for patients with mitochondrial disease

July 15, 2015

Gene-based cures for human diseases are now on the horizon

Discovery could improve in vitro fertilization success rates for women around the world

July 07, 2015

Scientists at Oregon Health & Science University, Stanford University, University of Valencia and IGENOMIX have discovered that chromosomal abnormalities in human embryos created for in vitro fertilization, or IVF, can be predicted within the first 30 hours of development at the cell-1 stage which results from the union of a female egg and male sperm.